Search
for
Sort by
Research 781–810 of 1000+
- Premature hair graying: a multifaceted phenomenon
- Pharmacological Activity of Cepharanthine
- Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Bio-Pulsed Stimulation Effectively Improves the Production of Avian Mesenchymal Stem Cell-Derived Extracellular Vesicles That Enhance the Bioactivity of Skin Fibroblasts and Hair Follicle Cells
- Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Alopecia areata: medical treatments
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis
- Melatonin/Chitosan Biomaterials for Wound Healing and Beyond: A Multifunctional Therapeutic Approach
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
- Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Relationship of Hair Regrowth Pattern in Alopecia Areata Patches According to DIMT Classification with Treatment Modalities and Patch Size: A Retrospective Cross-Sectional Analysis
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- LAM/TSC Cell Migration to Uterus in an Experimental Model of Lymphangioleiomyomatosis. Regulation by Anti-Epidermal Growth Factor Receptor Antibody and Rapamycin
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- ApoBDs: a paradigm shift from cellular debris to therapeutic vehicles
- Protein Immobilization on Bacterial Cellulose for Biomedical Application
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Current Progress Regarding Cordyceps militaris, Its Metabolite Function, and Its Production